Return On Assets of INTEGRATED BIOPHARMA INC from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
INTEGRATED BIOPHARMA INC quarterly and annual Return On Assets in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • INTEGRATED BIOPHARMA INC Return On Assets for the quarter ending 30 Sep 2025 was 2.6%, a 61% increase year-over-year.
  • INTEGRATED BIOPHARMA INC annual Return On Assets for 2025 was 3.2%, a 643% increase from 2024.
  • INTEGRATED BIOPHARMA INC annual Return On Assets for 2024 was 0.42%.
  • INTEGRATED BIOPHARMA INC annual Return On Assets for 2023 was -0.13%, a 101% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 2.6% +1% +61% 01 Jul 2025 30 Sep 2025
Q2 2025 3.2% +2.7% +643% 01 Apr 2025 30 Jun 2025
Q1 2025 4.8% +5.3% 01 Jan 2025 31 Mar 2025
Q4 2024 3.5% +5% 01 Oct 2024 31 Dec 2024
Q3 2024 1.6% +1.9% 01 Jul 2024 30 Sep 2024
Q2 2024 0.42% +0.55% 01 Apr 2024 30 Jun 2024
Q1 2024 -0.44% -5.9% -108% 01 Jan 2024 31 Mar 2024
Q4 2023 -1.5% -9.8% -118% 01 Oct 2023 31 Dec 2023
Q3 2023 -0.22% -13% -102% 01 Jul 2023 30 Sep 2023
Q2 2023 -0.13% -15% -101% 01 Apr 2023 30 Jun 2023
Q1 2023 5.4% -21% -79% 01 Jan 2023 31 Mar 2023
Q4 2022 8.4% -20% -71% 01 Oct 2022 31 Dec 2022
Q3 2022 12% -17% -58% 01 Jul 2022 30 Sep 2022
Q2 2022 15% -17% -53% 01 Apr 2022 30 Jun 2022
Q1 2022 26% +4.4% +20% 01 Jan 2022 31 Mar 2022
Q4 2021 28% +6.5% +30% 01 Oct 2021 31 Dec 2021
Q3 2021 30% +7.7% +35% 01 Jul 2021 30 Sep 2021
Q2 2021 32% +12% +60% 01 Apr 2021 30 Jun 2021
Q1 2021 22% +9% +70% 01 Jan 2021 31 Mar 2021
Q4 2020 22% +9.3% +74% 01 Oct 2020 31 Dec 2020
Q3 2020 22% +13% +151% 01 Jul 2020 30 Sep 2020
Q2 2020 20% +12% +147% 01 Apr 2020 30 Jun 2020
Q1 2020 13% +2% +18% 01 Jan 2020 31 Mar 2020
Q4 2019 13% +3.5% +39% 01 Oct 2019 31 Dec 2019
Q3 2019 8.7% +2.4% +39% 01 Jul 2019 30 Sep 2019
Q2 2019 8% +3.3% +72% 01 Apr 2019 30 Jun 2019
Q1 2019 11% 01 Jan 2019 31 Mar 2019
Q4 2018 9% 01 Oct 2018 31 Dec 2018
Q3 2018 6.3% 01 Jul 2018 30 Sep 2018
Q2 2018 4.7% 01 Apr 2018 30 Jun 2018
Q1 2016 0.78% -5% -86% 01 Jan 2016 31 Mar 2016
Q4 2015 -0.29% -3.5% -109% 01 Oct 2015 31 Dec 2015
Q3 2015 4.6% +2.6% +128% 01 Jul 2015 30 Sep 2015
Q2 2015 5.8% +4.6% +410% 01 Apr 2015 30 Jun 2015
Q1 2015 5.8% -2.9% -34% 01 Jan 2015 31 Mar 2015
Q4 2014 3.2% -4.4% -58% 01 Oct 2014 31 Dec 2014
Q3 2014 2% -8.6% -81% 01 Jul 2014 30 Sep 2014
Q2 2014 1.1% +0.41% +56% 01 Apr 2014 30 Jun 2014
Q1 2014 8.7% +26% 01 Jan 2014 31 Mar 2014
Q4 2013 7.6% +28% 01 Oct 2013 31 Dec 2013
Q3 2013 11% +46% 01 Jul 2013 30 Sep 2013
Q2 2013 0.73% +24% 01 Apr 2013 30 Jun 2013
Q1 2013 -18% -0.43% -2.5% 01 Jan 2013 31 Mar 2013
Q4 2012 -20% 01 Oct 2012 31 Dec 2012
Q3 2012 -35% 01 Jul 2012 30 Sep 2012
Q2 2012 -23% 01 Apr 2012 30 Jun 2012
Q1 2012 -17% 01 Jan 2012 31 Mar 2012

INTEGRATED BIOPHARMA INC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 3.2% +2.7% +643% 01 Jul 2024 30 Jun 2025
2024 0.42% +0.55% 01 Jul 2023 30 Jun 2024
2023 -0.13% -15% -101% 01 Jul 2022 30 Jun 2023
2022 15% -17% -53% 01 Jul 2021 30 Jun 2022
2021 32% +12% +60% 01 Jul 2020 30 Jun 2021
2020 20% +12% +147% 01 Jul 2019 30 Jun 2020
2019 8% +3.3% +72% 01 Jul 2018 30 Jun 2019
2018 4.7% +5.6% 01 Jul 2017 30 Jun 2018
2017 -0.97% -7.2% -116% 01 Apr 2017 31 Mar 2018
2016 6.2% +0.44% +7.6% 01 Apr 2016 31 Mar 2017
2015 5.8% +4.6% +410% 01 Jul 2014 30 Jun 2015
2014 1.1% +0.41% +56% 01 Jul 2013 30 Jun 2014
2013 0.73% +24% 01 Jul 2012 30 Jun 2013
2012 -23% 01 Jul 2011 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.